NONAGON

Nonagon provides a user-friendly, cost-effective, all-in-one solution that allows physicians to examine their patients remotely, augmenting standard video or telephonic-based telehealth with clinically valid physical examination data. Its solution consists of a clinically valid, FDA-cleared device for patients to do nine physical examinations supported by a mobile app, and a cloud-based patient-management platform for physicians. Nonagon aims to improve healthcare and enhance the quality of life for patients by serving both healthcare providers and patients. The solution is accessible to the general public through healthcare providers, pharmacy chains, and retail chains. Nonagon's business model is straightforward and affordable, making it accessible to the broader population. Additionally, Nonagon seeks to enhance retailers' existing healthcare strategies and foster customer engagement and loyalty by providing high-quality, easily accessible primary and pediatric healthcare solutions.

NONAGON has raised $1.25M in total funding across 3 rounds. The company is currently at the A stage. Key investors include BigIL, GlenRock Group, Esplanade Healthcare Ventures.

NONAGON operates in Health Tech & Life Sciences, Medical Devices, Medical Monitors, Digital Healthcare, Patient Remote Monitoring, with core technologies in Sensing, Platforms & Interfaces, Mobile, Software. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Providers, Insurance Companies.

NONAGON is based in HaEshel St, Caesarea, Israel.